Antibiotic resistant bacterial infections are treated using alternative drug combinations and novel therapies.
Multiple studies demonstrate that antibiotic-resistant infections are actively managed and treated using novel drug combinations, such as antibiotic-adjuvant or phage-antibiotic therapies, alongside innovative alternative approaches.
The claim is specific and empirical, stating that antibiotic resistant bacterial infections are treated using alternative drug combinations and novel therapies. All provided papers support this by detailing specific combinations (e.g., colistin-EDTA, phage-antibiotic) and novel therapeutic strategies (e.g., photodynamic inactivation, nanomedicine, targeted radioimmunotherapy) designed to combat resistant strains and biofilms. Therefore, the evidence strongly supports the claim.
Aye Shein. Mechanisms of colistin resistance and the antimicrobial effects of antibiotic and adjuvant combination on colistin-resistant Klebsiella pneumoniae. https://doi.org/10.58837/chula.the.2021.244
Paper [0] demonstrates that combining colistin with an EDTA adjuvant successfully treats resistant Klebsiella pneumoniae infections.
See more details
Seyed Jalil Mousavi, Hasan Nazari, Sayed Hussain Mosawi. Phage-Antibiotic Combination Therapy for Antibiotic-Resistant Bacteria; Synergistic Mechanisms and Clinical Applications: A Systematic Review. 2026. https://doi.org/10.60141/ajid.126
Paper [1] provides a systematic review showing that phage-antibiotic combinations synergistically treat multidrug-resistant bacterial infections.
Jennifer M. Soares, Vanderlei S. Bagnato, Kate C. Blanco.. Synergistic enhancement effects of antibiotic combination with photodynamic inactivation. 2022. https://doi.org/10.1364/laop.2022.w4a.29
Paper [2] shows that combining photodynamic inactivation with antibiotics restores bacterial sensitivity and creates synergistic therapeutic effects.
Archana Bagre, Payal Saiju, Amrendra Pratap Yadav. Novel Strategies for Targeting Biofilm-Associated Bacterial Resistance. 2026. https://doi.org/10.2174/9798898813451126010008
Paper [4] discusses multidisciplinary novel strategies, such as nanotechnology and smart delivery systems, to treat drug-resistant biofilm infections.
Zijian Ye. Novel Therapeutic Strategies for Staphylococcus aureus Biofilm Infections. https://doi.org/10.33540/3602
Paper [5] highlights novel therapeutic strategies like nanomedicine and targeted radioimmunotherapy to overcome Staphylococcus aureus biofilm-associated resistance.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt